389 related articles for article (PubMed ID: 15900559)
1. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
2. Experimental efficacy of an everolimus eluting cobalt chromium stent.
Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
[TBL] [Abstract][Full Text] [Related]
3. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
4. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
6. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model.
Carter AJ; Aggarwal M; Kopia GA; Tio F; Tsao PS; Kolata R; Yeung AC; Llanos G; Dooley J; Falotico R
Cardiovasc Res; 2004 Sep; 63(4):617-24. PubMed ID: 15306217
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
9. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
10. Coronary stenting with a novel stainless steel balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model.
Carter AJ; Laird JR; Kufs WM; Bailey L; Hoopes TG; Reeves T; Farb A; Virmani R
J Am Coll Cardiol; 1996 Apr; 27(5):1270-7. PubMed ID: 8609355
[TBL] [Abstract][Full Text] [Related]
11. ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?
Buellesfeld L; Grube E
Herz; 2004 Mar; 29(2):167-70. PubMed ID: 15054589
[TBL] [Abstract][Full Text] [Related]
12. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model.
Prunotto M; Vignolini C; Lolli V; Black A; Gaggianesi S; Santarelli A; Galloni M
J Biomed Mater Res A; 2009 Mar; 88(4):872-9. PubMed ID: 18360883
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
[TBL] [Abstract][Full Text] [Related]
14. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
[TBL] [Abstract][Full Text] [Related]
16. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
17. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
[TBL] [Abstract][Full Text] [Related]
18. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
[TBL] [Abstract][Full Text] [Related]
19. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
20. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Colombo A; Leon MB; Moses JW; Iversen P
Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
